Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
@yeeepyeeep A mí lo que me alucina es que ese mensaje encima venga de un psicólogo. Tanto "entender el contexto psicosocial de la gente", para que no lo entienda y encima pretender generar un sentimiento de vergüenza y culpa.